Baron Capital, an investment Management Company, released its fourth quarter 2025 investor letter for its “Baron Opportunity Fund”. A copy of the letter can be downloaded here. The Fund returned 4.63% (Institutional Shares) in Q4 2025, outperforming the Russell 3000 Growth Index’s (the Benchmark) 1.14% gain and the S&P 500 Index’s 2.66% return. The Fund appreciated 19.73% for the full year, surpassing the benchmark’s 18.15% and the S&P’s 17.88% returns. A turbulent year ended with moderate improvements in the fourth quarter. Moderating tariff impacts, robust corporate earnings, and continued monetary easing supported fourth-quarter gains. The Fund management focuses on prioritizing significant secular growth trends, including AI, space exploration and technology, autonomous transportation, robotics, digital commerce, media, finance, advanced therapeutics, and minimally invasive surgery that disrupt businesses and create long-term profitable growth opportunities. This focus led to the Fund’s outperformance in the year. In addition, please check the Fund’s top five holdings to know its best picks in 2025.
In its fourth-quarter 2025 investor letter, Baron Opportunity Fund highlighted stocks like Heartflow, Inc. (NASDAQ:HTFL). Heartflow, Inc. (NASDAQ:HTFL) is a medical device company focuses on AI driven non-invasive solutions for diagnosing and managing coronary artery diseases. On March 17, 2026, Heartflow, Inc. (NASDAQ:HTFL) stock closed at $22.52 per share. One-month return of Heartflow, Inc. (NASDAQ:HTFL) was -4.90%, and YTD its shares lost 22.74%. Heartflow, Inc. (NASDAQ:HTFL) has a market capitalization of $1.92 billion.
Baron Opportunity Fund stated the following regarding Heartflow, Inc. (NASDAQ:HTFL) in its fourth quarter 2025 investor letter:
“Heartflow, Inc. (NASDAQ:HTFL) is a medical device company providing an AI powered engine to diagnose heart disease. Heart disease is responsible for 1 in 5 deaths in the U.S., and every 40 seconds someone has a heart attack. There is an urgent need to quickly and accurately catch this disease before it reaches this stage. Heartflow’s solution provides a minimally invasive way to catch blockages in the heart vessels, reducing both false negatives and false positives relative to standard of care today. The company has a strong competitive moat, with a repository of 110 million images supplemented by human-aided training that has taken over 10 years to build. We like the asset light nature of the business, along with the margin expansion opportunity as the AI algorithm gets smarter with scale and data, enabling Heartflow to reduce the number of employee hours involved in real-time workflows. Heartflow is in the very early innings of its growth ramp. The company has over 600 peer-reviewed publications, its solution has been approved by the FDA, and its core product has 99% insurance coverage. The company is only low single-digit penetrated into its addressable market and additionally is launching a new add-on product for plaque analysis that will utilize the same analytics backbone and thus come in at extremely high margins. We believe Heartflow is a model for the next generation of health care companies, which will be powered by big data and AI to make health care more efficient, less costly, and save lives on a broad scale.”
Heartflow, Inc. (NASDAQ:HTFL) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 16 hedge fund portfolios held Heartflow, Inc. (NASDAQ:HTFL) at the end of the fourth quarter, compared to 23 in the previous quarter. While we acknowledge the risk and potential of Heartflow, Inc. (NASDAQ:HTFL) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Heartflow, Inc. (NASDAQ:HTFL) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Heartflow, Inc. (NASDAQ:HTFL) and shared the list of newly-listed NASDAQ stocks to buy. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
